Solbjørg Sagedal - Concepedia

Author

Solbjørg Sagedal

Oslo University Hospital

Also Known As

S Sagedal, S. Sagedal, Sagedal, Solbjørg, Solbjorg Sagedal, Solbjørg Sagedal

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Aarhus University Med-Storm Innovation (Norway)Norwegian University of Science and Technology

About

Solbjørg Sagedal is an author at Oslo University Hospital specializing in medicine, transplantation, and kidney transplant.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.3K
2	Diabetes	3	3	628
3	Public Health	1	1	340
4	Epidemiology	1	1	340
5	Hepatology	1	1	14

Solbjørg Sagedal

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Jøran Hjelmesæth, Anders Hartmann, T. Leivestad, Kidney International Islet TransplantationTransplantationCardiovascular DiseaseDiabetesGraft Survival	2006	340
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival Solbjørg Sagedal, Anders Hartmann, Knut P. Nordal, Kidney International TransplantationEarly Cytomegalovirus InfectionKidney TransplantKidney TransplantationImmunology	2004	339
The Impact of Cytomegalovirus Infection and Disease on Rejection Episodes in Renal Allograft Recipients Solbjørg Sagedal, Knut P. Nordal, Anders Hartmann, American Journal of Transplantation	2002	290
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation J. Hjelmes�th, Solbjørg Sagedal, Anders Hartmann, Diabetologia TransplantationKidney TransplantDiabetesImmunologyGraft Survival	2004	227
The Natural Course of Cytomegalovirus Infection and Disease in Renal Transplant Recipients Anders Hartmann, Solbjørg Sagedal, Jøran Hjelmesæth Transplantation Cytomegalovirus InfectionTransplantationKidney TransplantKidney TransplantationImmunology	2006	120
A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation Knut T. Smerud, Szilveszter Dolgos, Inge Christoffer Olsen, American Journal of Transplantation	2012	63
Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets Solbjørg Sagedal, Anders Hartmann, Kristina Sundstrøm, Nephrology Dialysis Transplantation	2001	62
Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients Jøran Hjelmesæth, Thor Ueland, Allan Flyvbjerg, Journal of the American Society of Nephrology Cardiovascular DeathTranslational MedicineRenal FunctionRenal Transplant PatientsGraft Survival	2006	61
Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk Solbjørg Sagedal, Halvor Rollag, Anders Hartmann Clinical Transplantation Cytomegalovirus InfectionTransplantationKidney TransplantKidney TransplantationImmunodeficiencies	2007	61
Effect of immune modulation on TT virus (TTV) and TTV‐like‐mini‐virus (TLMV) viremia Eva Merethe Moen, Solbjørg Sagedal, Kristian Bjøro, Journal of Medical Virology Viral PathogenesisImmunologyImmunodominanceTt VirusImmune System	2003	60

Page 1